deCODE Genetics, An Amgen Subsidiary, And SomaLogic Announce Collaboration To Perform Large-Scale Protein Analysis Of Up To 40,000 Human Samples

Largest-ever Protein Measurement Study Enhances deCODE's Efforts in Basic Research, Drug Discovery and Novel Protein-based DiagnosticsREYKJAVIK, Iceland and BOULDER, Colo., Dec. 13, 2018 /PRNewswire/ -- deCODE genetics, an Amgen subsidiary, and SomaLogic, Inc. today announced a collaboration that brings together SomaLogic's expertise in human proteins with deCODE's expertise in human genetics. The collaboration combines deCODE's rich data sets with SomaLogic's leading protein measurement capabilities to enhance the understanding of how human disease and health are mediated through proteins to influence health outcomes."I am excited to see what deep proteomic analysis will add to what we alre...
Source: Amgen News Release - Category: Pharmaceuticals Tags: Uncategorized Source Type: news